Regeneron Pharma Inc. (REGN) reported a third-quarter net loss of $1.015 million or $0.01 per share compared to a net loss of $19.084 million or $0.24 per share last year.
On average, 11 analysts polled by Thomson Reuters expected the company to report a loss of $0.21 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues increased to $117.455 million from $65.584 million last year. Analysts expected revenue of $84.08 million for the quarter.
For comments and feedback: editorial@rttnews.com